Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,718.00p
   
  • Change Today:
    -38.00p
  • 52 Week High: 2,792.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 42,156
  • Market Cap: £1,134.42m
  • RiskGrade: 128

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
30-Jun-19 Interim 8.90p 04-Apr-19 07-Mar-19 08-Mar-19
  Final 18.80p 29-Nov-19 07-Nov-19 08-Nov-19
30-Jun-20 Interim 9.40p 02-Apr-20 05-Mar-20 06-Mar-20
  Final 19.70p 11-Dec-20 19-Nov-20 20-Nov-20
30-Jun-21 Interim 10.30p 01-Apr-21 04-Mar-21 05-Mar-21
  Final 21.70p 10-Dec-21 18-Nov-21 19-Nov-21
30-Jun-22 Interim 10.30p 31-Mar-22 03-Mar-22 04-Mar-22
  Final 21.70p 09-Dec-22 17-Nov-22 18-Nov-22
30-Jun-23 Interim 10.30p 30-Mar-23 02-Mar-23 03-Mar-23
  Final 21.70p 08-Dec-23 09-Nov-23 10-Nov-23
30-Jun-24 Interim 10.30p 28-Mar-24 29-Feb-24 01-Mar-24

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 1,718.00p
Change Today -38.00p
% Change -2.16 %
52 Week High 2,792.00
52 Week Low 1,637.00
Volume 42,156
Shares Issued 66.03m
Market Cap £1,134.42m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.64% below the market average95.64% below the market average95.64% below the market average95.64% below the market average95.64% below the market average
96.23% below the sector average96.23% below the sector average96.23% below the sector average96.23% below the sector average96.23% below the sector average
Price Trend
62.29% below the market average62.29% below the market average62.29% below the market average62.29% below the market average62.29% below the market average
19.30% above the sector average19.30% above the sector average19.30% above the sector average19.30% above the sector average19.30% above the sector average
Income
86.2% below the market average86.2% below the market average86.2% below the market average86.2% below the market average86.2% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
69.5% below the market average69.5% below the market average69.5% below the market average69.5% below the market average69.5% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 19-Apr-2024

Time Volume / Share Price
16:35 22,456 @ 1,718.00p
16:35 1 @ 1,718.00p
16:35 99 @ 1,718.00p
16:35 1,009 @ 1,718.00p
16:35 57 @ 1,718.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page